153 related articles for article (PubMed ID: 38662655)
1. Polypharmacy and associated factors in South Korean elderly patients with dementia: An analysis using National Health Insurance claims data.
Kim HL; Lee HJ
PLoS One; 2024; 19(4):e0302300. PubMed ID: 38662655
[TBL] [Abstract][Full Text] [Related]
2. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
Joung KI; Shin JY; Cho SI
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
[TBL] [Abstract][Full Text] [Related]
3. Prescribed drugs and polypharmacy in healthcare service users in South Korea: an analysis based on National Health Insurance Claims data.
Park HY; Ryu HN; Shim MK; Sohn HS; Kwon JW
Int J Clin Pharmacol Ther; 2016 May; 54(5):369-77. PubMed ID: 27007996
[TBL] [Abstract][Full Text] [Related]
4. Factors related to polypharmacy and hyper-polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea.
Cho HJ; Chae J; Yoon SH; Kim DS
Clin Transl Sci; 2023 Feb; 16(2):193-205. PubMed ID: 36401587
[TBL] [Abstract][Full Text] [Related]
5. The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
Park HY; Park JW; Song HJ; Sohn HS; Kwon JW
PLoS One; 2017; 12(1):e0169463. PubMed ID: 28056068
[TBL] [Abstract][Full Text] [Related]
6. Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea.
Park HY; Park JW; Sohn HS; Kwon JW
Drug Saf; 2017 Nov; 40(11):1109-1118. PubMed ID: 28634824
[TBL] [Abstract][Full Text] [Related]
7. Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort.
Kang H; Hong SH
Sci Rep; 2019 Jul; 9(1):10440. PubMed ID: 31320704
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of polypharmacy among Korean elderly.
Kim HA; Shin JY; Kim MH; Park BJ
PLoS One; 2014; 9(6):e98043. PubMed ID: 24915073
[TBL] [Abstract][Full Text] [Related]
9. Utilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims database.
Kim JY; Kim HJ; Jung SY; Kim KI; Song HJ; Lee JY; Seong JM; Park BJ
BMC Cardiovasc Disord; 2012 Jul; 12():60. PubMed ID: 22849621
[TBL] [Abstract][Full Text] [Related]
10. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
11. Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: a nationwide database study.
Lin SK; Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2015 Feb; 161():108-15. PubMed ID: 25527314
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric inpatient expenditures and public health insurance programmes: analysis of a national database covering the entire South Korean population.
Chung W
BMC Health Serv Res; 2010 Sep; 10():263. PubMed ID: 20819235
[TBL] [Abstract][Full Text] [Related]
13. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Hoffmann F; van den Bussche H; Wiese B; Schön G; Koller D; Eisele M; Glaeske G; Scherer M; Kaduszkiewicz H
BMC Psychiatry; 2011 Dec; 11():190. PubMed ID: 22145796
[TBL] [Abstract][Full Text] [Related]
14. Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010-2019.
Cho HJ; Chae J; Yoon SH; Kim DS
Front Pharmacol; 2022; 13():866318. PubMed ID: 35614938
[No Abstract] [Full Text] [Related]
15. Prescribing patterns of polypharmacy in Korean pediatric patients.
Jeon SM; Park S; Rhie SJ; Kwon JW
PLoS One; 2019; 14(10):e0222781. PubMed ID: 31574095
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence and Characteristics of Older Japanese Adults with Polypharmacy, Based on Regionally Representative Health Insurance Claims Data.
Amano H; Fujimoto K; Fujimori M; Saka N; Nomura K; Tanihara S
Acta Med Okayama; 2020 Feb; 74(1):41-48. PubMed ID: 32099247
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anticholinergic burden and risk factors amongst the older population: analysis of insurance claims data of Korean patients.
Jun K; Ah YM; Hwang S; Chung JE; Lee JY
Int J Clin Pharm; 2020 Apr; 42(2):453-461. PubMed ID: 32281075
[TBL] [Abstract][Full Text] [Related]
18. Prescription of potentially inappropriate medication in Korean older adults based on 2012 Beers Criteria: a cross-sectional population based study.
Nam YS; Han JS; Kim JY; Bae WK; Lee K
BMC Geriatr; 2016 Jun; 16():118. PubMed ID: 27255674
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
Baik D; Yu YM; Jung SY; Kang HY
BMC Geriatr; 2022 Jul; 22(1):609. PubMed ID: 35864474
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic Use Among the Elderly With Alzheimer Disease in South Korea: A Population-based Study.
Joung KI; Shin JY; Kim S; Cho SI
Alzheimer Dis Assoc Disord; 2020; 34(3):238-243. PubMed ID: 31913963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
